Status:
NOT_YET_RECRUITING
Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya
Lead Sponsor:
Nagasaki University
Conditions:
Tuberculosis
Pulmonary Tuberculoses
Eligibility:
All Genders
18+ years
Brief Summary
Tuberculosis (TB) can be treated; however, the standard 6-month treatment is long and challenging for many patients, and 10-20% still don't recover well by the end of treatment. Thus, it's important t...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older
- Patients with a recent diagnosis of bacteriologically confirmed PTB who have not yet initiated TB treatment.
- Patients who are willing and able to visit to the facility for follow-up sample collection and interviews.
- Patients who are willing and able to provide written informed consent to participate in the study.
Exclusion
- \- Patients with a history of TB treatment within the past 6 months, including retreatment.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07157904
Start Date
January 1 2026
End Date
July 1 2027
Last Update
September 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mbagathi County Referral Hospital
Nairobi, Kenya
2
Rhodes Chest Clinic
Nairobi, Kenya